Cedron Jorge Andres 4

What Happened Jorge Andres Cedron, Chief Legal Officer of Orthofix Medical, sold a total of 2,775 shares in two open-market transactions to satisfy tax withholding on restricted stock units. On 2026-03-04 he sold 1,405 shares at a weighted average price of $12.92 for proceeds of $18,147; on 2026-03-05 he sold 1,370 shares at a weighted average price of $12.55 for proceeds of $17,195. Total proceeds were about $35,342. These sales were sell-to-cover transactions tied to RSU settlement (routine tax withholding), not discretionary market timing.

Key Details

• Transaction dates and amounts:
  • 2026-03-04: 1,405 shares sold @ $12.92 (total ~$18,147). (Footnote F2: weighted-average; trades ranged $12.80–$13.03.)
  • 2026-03-05: 1,370 shares sold @ $12.55 (total ~$17,195). (Footnote F4: weighted-average; trades ranged $12.48–$12.72.)
• Reason: Footnote F1 states these sales were made to satisfy tax withholding on RSU settlement per a pre-existing sell-to-cover requirement and were made without the reporting person’s discretion.
• Ownership after transaction: Form notes inclusion of 53,902 previously reported restricted stock units (Footnote F3). The Form 4 did not list a single consolidated post-transaction beneficial ownership total in the provided details.
• Filing timeliness: Report filed 2026-03-06 for transactions on 2026-03-04 and 2026-03-05 — appears timely (within SEC two-business-day Form 4 reporting window).
• Disclosure offer: Footnote F2 indicates the reporting person will provide a breakdown of shares sold at each separate price on request.

Context Sell-to-cover transactions are common when RSUs vest and shares are sold solely to cover taxes; they are routine and do not necessarily signal the insider’s view on the company’s prospects. The filing is informational: it documents the tax-related disposals rather than a voluntary sale indicating sentiment.